technology transfer Archives | ��ϳԹ��Դ

Tech Transfer: Innovation HQ

Phil Renna — Wed, 04 Feb 2026 12:30:42 +0000

Technology transfer is about building bridges between science and society. It helps ensure that discoveries and innovations don’t stay confined to the lab but become practical solutions. Protecting this intellectual property and forming industry partnerships are vital challenges that guide ideas toward commercialization, according to Andrew Whiteley, Vice President of Business Development and Technology Transfer...

The post Tech Transfer: Innovation HQ appeared first on ��ϳԹ��Դ.

President’s essay: The continuous cycle of discovery

Communications Department — Thu, 30 May 2024 11:30:43 +0000

��ϳԹ��Դ (CSHL) is a vibrant intellectual community that enables groundbreaking discovery. Our idyllic setting and state-of-the-art facilities offer a uniquely supportive environment for bioscience breakthroughs. However, CSHL’s community is not bound by the geography of our campus. Science worldwide has been strengthened by people who spend time on our campus and by...

The post President’s essay: The continuous cycle of discovery appeared first on ��ϳԹ��Դ.

CSHL and Northwell Health extend strategic affiliation

Phil Renna — Mon, 29 Apr 2024 13:30:22 +0000

The historic agreement aims to translate basic bioscience into a clinical setting, providing cancer patients with greater access to personalized healthcare. NEW YORK, NY — Leaders from two of New York’s preeminent bioscience and healthcare institutions came together at Carnegie Hall to acknowledge the signing of an update to their affiliation agreement initiated in 2015....

The post CSHL and Northwell Health extend strategic affiliation appeared first on ��ϳԹ��Դ.

Bald eagles fight in flight

Nick Wurm — Thu, 25 Jan 2024 12:30:01 +0000

There’s been a surge of bald eagle sightings on campus. CSHL’s Vlad Drozdoff brings us an amazing close-up look at these birds in action.

The post Bald eagles fight in flight appeared first on ��ϳԹ��Դ.

Dream big: A powerful vision for CSHL research

Jennifer Michalowski — Tue, 02 Jan 2024 12:30:26 +0000

Leemor Joshua-Tor describes her new role as director of research at ��ϳԹ��Դ (CSHL) in no uncertain terms. “I am going to enable our faculty to carry out their dreams,” she says. CSHL scientists tend to dream big. Joshua-Tor knows that to map the brain’s circuits, transform our understanding of cancer biology, and...

The post Dream big: A powerful vision for CSHL research appeared first on ��ϳԹ��Դ.

Breaking new ground: For science and society

Communications Department — Mon, 13 Nov 2023 15:00:36 +0000

It is with great admiration and respect that I applaud Marilyn Simons, Chair of the ��ϳԹ��Դ (CSHL) Board of Trustees, on the launch of this institution’s most ambitious fundraising campaign. “Foundations for the Future” will raise $500 million to propel the institution’s bioscience research and education programs to new heights and maximal...

The post Breaking new ground: For science and society appeared first on ��ϳԹ��Դ.

Laying the groundwork for drug discoveries

Luis Sandoval — Tue, 08 Aug 2023 11:30:01 +0000

Imagine a ��ϳԹ��Դ (CSHL) scientist walks out onto the biotech “Shark Tank” stage to pitch promising biomedical research to venture capitalists. The ask? Millions of dollars. The bait? Life-saving technology. If this kind of cutthroat dealmaking sounds beyond the scope of even the most gifted research scientist, well, it certainly can be....

The post Laying the groundwork for drug discoveries appeared first on ��ϳԹ��Դ.

CSHL and Deerfield Management launch Harbor Discoveries

Communications Department — Thu, 12 Jan 2023 16:00:11 +0000

The following press release was originally issued by Deerfield Management Company on January 5, 2023, under the headline, “��ϳԹ��Դ and Deerfield Management Launch Harbor Discoveries to Advance New Therapeutics.” ��ϳԹ��Դ (CSHL) and healthcare investment firm Deerfield Management have announced a research and development collaboration to help bring next-generation therapeutics...

The post CSHL and Deerfield Management launch Harbor Discoveries appeared first on ��ϳԹ��Դ.

Envisagenics and Biogen partner for RNA splicing research

Luis Sandoval — Wed, 09 Jun 2021 12:00:04 +0000

The ��ϳԹ��Դ (CSHL) spin-out company Envisagenics and Biogen Inc. announced a new collaboration on May 13, 2021. This collaboration aims to advance RNA research in central nervous system diseases by leveraging the Envisagenics artificial intelligence–based platform called SpliceCore®. Genes, encoded in DNA, are transcribed into the related language of RNA. RNA is...

The post Envisagenics and Biogen partner for RNA splicing research appeared first on ��ϳԹ��Դ.

New incubator model for CSHL spin-outs

Dagnia Zeidlickis — Mon, 07 Jun 2021 12:40:14 +0000

��ϳԹ��Դ (CSHL) is collaborating with Autobahn Labs, a new life sciences incubator, to catalyze the Laboratory’s early-stage discovery programs into spin-out companies that commercialize transformational new therapies. CSHL is a world leader in basic biological research and in target discovery for human genetic diseases like cancer. Autobahn will provide up to $5...

The post New incubator model for CSHL spin-outs appeared first on ��ϳԹ��Դ.

$11 million investment to develop fibroblast therapeutic

Communications Department — Mon, 26 Apr 2021 12:30:21 +0000

Mestag Therapeutics™, a new company developing innovative therapies and treatments for cancers and inflammatory diseases, has been launched with $11 million in seed financing. In collaboration with ��ϳԹ��Դ (CSHL), Mestag is pursuing a first-in-class therapeutic strategy that focuses on cells called fibroblasts, which can impede the effectiveness of traditional cancer treatments. The...

The post $11 million investment to develop fibroblast therapeutic appeared first on ��ϳԹ��Դ.

CSHL tops Bush Center’s Innovation Impact Productivity Score

Sara Roncero-Menendez — Mon, 13 Jul 2020 12:00:22 +0000

��ϳԹ��Դ (CSHL) is ranked #1 on Innovation Impact’s Productivity Score among Pure Research/Health Care Institutions, as well as #1 for Patent Citations by the George W. Bush Presidential Center. In their yearly report, “The Innovation Impact of U.S. Universities,” the Bush Center measures the innovations of American research institutions and highlights works...

The post CSHL tops Bush Center’s Innovation Impact Productivity Score appeared first on ��ϳԹ��Դ.

��ϳԹ��Դ announces exclusive license with plant breeding start-up Inari

Dagnia Zeidlickis — Tue, 16 Apr 2019 13:00:19 +0000

Cold Spring Harbor, NY — ��ϳԹ��Դ (CSHL) announced today an exclusive licensing agreement with partner Inari, a company that is advancing plant breeding by tapping nature’s genetic diversity. The technology developed by CSHL Professor and Howard Hughes Medical Institute Investigator Zachary Lippman allows Inari to tailor plant architecture and other traits in...

The post ��ϳԹ��Դ announces exclusive license with plant breeding start-up Inari appeared first on ��ϳԹ��Դ.

Breakthrough Prize laureates meet at CSHL

Communications Department — Thu, 06 Dec 2018 22:00:51 +0000

The joint recipients of the 2019 Breakthrough Prize in Life Sciences, ��ϳԹ��Դ (CSHL) Professor Adrian Krainer and C. Frank Bennett of Ionis Pharmaceuticals, met for the first time since the award ceremony, at the Neurodegenerative Diseases meeting held November 28 through December 1 at CSHL. Recognized by Breakthrough for the development of...

The post Breakthrough Prize laureates meet at CSHL appeared first on ��ϳԹ��Դ.

The case for open and inclusive science

Communications Department — Fri, 08 Jun 2018 20:01:51 +0000

Science has been one of the most important contributors to American national strength over the past century, but particularly since the Second World War. During that extraordinary crisis, outstanding national leaders recognized the untapped power of discoveries in a broad range of disciplines, from chemistry and physics to biology and engineering. In 1944, President Franklin...

The post The case for open and inclusive science appeared first on ��ϳԹ��Դ.

Andrew Whiteley appointed VP of Business Development and Technology Transfer at CSHL

Sara Roncero-Menendez — Tue, 03 Apr 2018 20:41:37 +0000

Cold Spring Harbor, NY — ��ϳԹ��Դ (CSHL) today announced the appointment of life science business leader Andrew Whiteley as the new Vice President of Business Development and Technology Transfer. Whiteley, who has served as Executive in Residence at CSHL since November 2015, now leads a dedicated team that supports scientists in commercialization...

The post Andrew Whiteley appointed VP of Business Development and Technology Transfer at CSHL appeared first on ��ϳԹ��Դ.

Library of CRISPR targeting sequences increases power and accuracy of the gene-editing method

Peter Tarr — Thu, 20 Jul 2017 11:00:17 +0000

Cold Spring Harbor, NY — CRISPR, the gene-editing technology that has taken biology by storm, is now more powerful than ever. Scientists have assembled a library of RNA sequences that can be used by researchers to direct the CRISPR-cas9 complex to cut DNA with exquisite, unprecedented precision. Among other advantages, the new tool greatly increases...

The post Library of CRISPR targeting sequences increases power and accuracy of the gene-editing method appeared first on ��ϳԹ��Դ.

Executive in Residence to mentor scientific entrepreneurs at ��ϳԹ��Դ

Dagnia Zeidlickis — Fri, 15 Apr 2016 08:00:49 +0000

Biotech veteran Andrew Whiteley brings industry expertise to spin-offs Cold Spring Harbor, NY — Andrew Whiteley has joined the ��ϳԹ��Դ (CSHL) Office of Technology Transfer as the first Executive in Residence. Mr. Whiteley’s 30 years of experience in the life science industry will help the Laboratory’s entrepreneurial scientists launch and manage new...

The post Executive in Residence to mentor scientific entrepreneurs at ��ϳԹ��Դ appeared first on ��ϳԹ��Դ.

��ϳԹ��Դ and North Shore-LIJ announce strategic affiliation to accelerate benefits of cancer research to patients

Dagnia Zeidlickis — Thu, 02 Apr 2015 08:00:52 +0000

Cold Spring Harbor, NY — ��ϳԹ��Դ (CSHL) and the North Shore-LIJ Health System today announced a strategic affiliation to align CSHL’s world-class cancer research with North Shore-LIJ’s growing network of clinical services encompassing more than 16,000 new cancer cases annually across the New York metropolitan area. “This is a transformative affiliation for...

The post ��ϳԹ��Դ and North Shore-LIJ announce strategic affiliation to accelerate benefits of cancer research to patients appeared first on ��ϳԹ��Դ.

��ϳԹ��Դ engages Hairpin Technologies Inc. to license its short hairpin RNA (shRNA) technology

Communications Department — Tue, 31 Mar 2015 08:00:08 +0000

Cold Spring Harbor, NY — ��ϳԹ��Դ (CSHL) has engaged Hairpin Technologies Inc. to expand the commercial distribution and research use of short hairpin RNA (shRNA) technology. Hairpin Technologies will serve as CSHL’s exclusive agent for negotiating and executing new license agreements with potential licensees of CSHL’s U.S. and international patents covering the shRNA...

The post ��ϳԹ��Դ engages Hairpin Technologies Inc. to license its short hairpin RNA (shRNA) technology appeared first on ��ϳԹ��Դ.

technology transfer Archives | ���ϳԹ���Դ